{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T12:18:16Z","timestamp":1759580296495,"version":"3.37.3"},"reference-count":40,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objectives: To evaluate the incidence of venous thromboembolism (VTE) in hospitalized patients with COVID-19 who underwent diagnostic tests for suspected VTE, and to correlate the IMPROVE-DD score with the incidence of VTE in this cohort. Methods: This retrospective study included consecutive patients with COVID-19 and suspected VTE, admitted between March 2020 and September 2021 at a private hospital in Salvador (BA), Brazil, who underwent lower or upper limb venous Doppler ultrasound or chest angiotomography. Descriptive analyses and comparisons using the chi-square test were performed to identify factors potentially associated with the risk of VTE. Results: A total of 517 patients were included, with an in-hospital VTE incidence of 18.6% (96 events). Risk factors significantly associated with VTE included obesity, ICU admission, central venous catheter use, longer hospital stays, greater lung tomographic involvement\/severity, the need for mechanical ventilation, D-dimer levels at least twice the upper limit of normal (2xULN), and the IMPROVE-DD score. The mean IMPROVE-DD score among patients with VTE was 4.7 (\u00b13) versus 3.3 (\u00b12.4) in those without VTE (p &lt; 0.0001). D-dimer 2xULN was sensitive in identifying 94% of the 96 patients with VTE (p &lt; 0.0001). The in-hospital mortality rate was 14.1%, with higher rates observed in patients with VTE (24%) compared to those without VTE (11.9%) (p = 0.003). Conclusions: The incidence of VTE in hospitalized COVID-19 patients was high and correlated with increased mortality. The IMPROVE-DD score effectively identified patients at risk for in-hospital VTE, suggesting it could help to identify a high-risk subgroup that may benefit from extended thromboprophylaxis.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20240042","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:04:50Z","timestamp":1740171890000},"page":"e20240042","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of the IMPROVE-DD score in COVID-19 patients submitted to venous thromboembolism investigation at a hospital in Brazil"],"prefix":"10.36416","author":[{"given":"Ronney","family":"Argolo Ferreira1","sequence":"first","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal da Bahia, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian","family":"Zanatta1","sequence":"additional","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal da Bahia, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliane","family":"Bispo de Oliveira1","sequence":"additional","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal da Bahia, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janaina","family":"Ibele Carvalho Gomes1","sequence":"additional","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal da Bahia, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz","family":"Ritt2,3","sequence":"additional","affiliation":[{"name":"2. Escola Baiana de Medicina e Sa\u00fade P\u00fablica, Salvador (BA), Brasil. 3. Instituto D'Or de Pesquisa e Ensino, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Thereza","family":"Cavalcanti Rocha1,2,3","sequence":"additional","affiliation":[{"name":"1. Faculdade de Medicina, Universidade Federal da Bahia, Salvador (BA), Brasil. 2. Escola Baiana de Medicina e Sa\u00fade P\u00fablica, Salvador (BA), Brasil. 3. Instituto D'Or de Pesquisa e Ensino, Salvador (BA), Brasil."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22288","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.           CDC. People with Certain Medical Conditions | CDC [Internet]. 2024 [cited 2024 Nov 16]. Available from: https:\/\/www.cdc.gov\/covid\/risk-factors\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html","DOI":"10.1097\/qai.0000000000003403"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           CDC. Symptoms of COVID-19 | CDC [Internet]. 2024 [cited 2024 Nov 16]. Available from: https:\/\/www.cdc.gov\/covid\/signs-symptoms\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html","DOI":"10.1136\/bmj.n888"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           Gandhi RT. COVID-19: Clinical features - UpToDate [Internet]. UpToDate. 2024 [cited 2024 Nov 16]. Available from: https:\/\/www.uptodate.com\/contents\/covid-19-clinical-features?search=covid 19&source=covid19_landing&usage_type=main_section","DOI":"10.1097\/01.cot.0000494620.34618.ba"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS\u2010CoV\u20102 and COVID\u201019 susceptibility and severity. Immunol Rev. 2020;;296(1):205\u2013219. https:\/\/doi.org\/10.1111\/imr.12897","DOI":"10.1111\/imr.12897"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5.           Cuker A, Peyvandi F. COVID-19: Hypercoagulability - UpToDate [Internet]. UpToDate. 2024 [cited 2024 Nov 16]. Available from: https:\/\/www.uptodate.com\/contents\/covid-19-hypercoagulability?search=covid&source=covid19_landing&usage_type=main_section","DOI":"10.1097\/01.NPR.0000000000000237"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6.           Jim\u00e9nez D, Garc\u00eda-Sanchez A, Rali P, Muriel A, Bikdeli B, Ruiz-Artacho P, et al. Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-analysis. Chest. 2021;159(3):1182\u201396. https:\/\/doi.org\/10.1016\/j.chest.2020.11.005","DOI":"10.1016\/j.chest.2020.11.005"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Spyropoulos AC, Goldin M, Giannis D, Diab W, Wang J, Khanijo S, et al. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial . JAMA Intern Med. 2021;181(12):1612\u20131620. https:\/\/doi.org\/10.1001\/jamainternmed.2021.6203","DOI":"10.1001\/jamainternmed.2021.6203"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Spyropoulos AC, Cohen SL, Gianos E, Kohn N, Giannis D, Chatterjee S, et al. Validation of the IMPROVE\uf02dDD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19. Res Pract Thromb Haemost. 2021;5(2):296\u2013300. https:\/\/doi.org\/10.1002\/rth2.12486","DOI":"10.1002\/rth2.12486"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.           Goldin M, Lin SK, Kohn N, Qiu M, Cohen SL, Barish MA, et al. External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. J Thromb Thrombolysis. 2021;52(4):1032\u20135. https:\/\/doi.org\/10.1007\/s11239-021-02504-5","DOI":"10.1007\/s11239-021-02504-5"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10.        Giannis D, Allen SL, Tsang J, Flint S, Pinhasov T, Williams S, et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137(20):2838\u201347. https:\/\/doi.org\/10.1182\/blood.2020010529","DOI":"10.1182\/blood.2020010529"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scientific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID\u201019. J Thromb Haemost. 2020;18(8):1859\u201365. https:\/\/doi.org\/10.1111\/jth.14929","DOI":"10.1111\/jth.14929"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Spyropoulos AC, Lopes RD. Commissioned Commentary on the 2021 American Society of Hematology Guidelines on use of anticoagulation in patients with COVID-19 being discharged from the hospital. Blood Adv [Internet]. 2022 Mar 4. Available from: https:\/\/ashpublications.org\/bloodadvances\/article\/doi\/10.1182\/bloodadvances.2021006871\/484274\/Commissioned-Commentary-on-the-2021-American","DOI":"10.1182\/bloodadvances.2021006871"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Spyropoulos AC, Anderson FA, FitzGerald G, Decousus H, Pini M, Chong BH, et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140(3):706\u201314. https:\/\/doi.org\/10.1378\/chest.10-1944","DOI":"10.1378\/chest.10-1944"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        Gibson CM, Spyropoulos AC, Cohen AT, Hull RD, Goldhaber SZ, Yusen RD, et al. The IMPROVEDD VTE Risk Score: Incorporation of D-Dimer into the IMPROVE Score to Improve Venous Thromboembolism Risk Stratification. TH Open. 2017;1(1):e56\u2013e65. http:\/\/doi.org\/10.1055\/s-0037-1603929","DOI":"10.1055\/s-0037-1603929"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Longchamp G, Manzocchi-Besson S, Longchamp A, Righini M, Robert-Ebadi H, Blondon M. Proximal deep vein thrombosis and pulmonary embolism in COVID-19 patients: a systematic review and meta-analysis. Thromb J. 2021;19(1):15. https:\/\/doi.org\/10.1186\/s12959-021-00266-x","DOI":"10.1186\/s12959-021-00266-x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Chen X, Zhang S, Liu H, Zhang Q, Chen J, Zheng Q, et al. Effect of anticoagulation on the incidence of venous thromboembolism, major bleeding, and mortality among hospitalized COVID-19 patients: an updated meta-analysis. Front Cardiovasc Med. 2024;11:1381408. https:\/\/doi.org\/10.3389\/fcvm.2024.1381408","DOI":"10.3389\/fcvm.2024.1381408"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Al-Dorzi HM, Alqirnas MQ, Hegazy MM, Alghamdi AS, Alotaibi MT, Albogami MT, et al. Prevalence and Risk Factors of Venous Thromboembolism in Critically Ill Patients with Severe COVID-19 and the Association between the Dose of Anticoagulants and Outcomes. J Crit Care Med. 2022;8(4):249\u201358. https:\/\/doi.org\/10.2478\/jccm-2022-0023","DOI":"10.2478\/jccm-2022-0023"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.        Asakura H, Ogawa H. COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int J Hematol [Internet]. 2021;113(1):45\u201357. https:\/\/doi.org\/10.1007\/s12185-020-03029-y","DOI":"10.1007\/s12185-020-03029-y"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19.        Violi F, Ceccarelli G, Cangemi R, Cipollone F, D\u2019Ardes D, Oliva A, et al. Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality. Intern Emerg Med. 2021;16(5):1231\u20137. https:\/\/doi.org\/10.1007\/s11739-020-02621-8","DOI":"10.1007\/s11739-020-02621-8"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Palareti G, Legnani C, Cosmi B, Antonucci E, Erba N, Poli D, et al. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study. Int J Lab Hematol. 2016;38(1):42\u20139. https:\/\/doi.org\/10.1111\/ijlh.12426","DOI":"10.1111\/ijlh.12426"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.        Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. D\u2010dimer levels on admission to predict in\u2010hospital mortality in patients with Covid\u201019. J Thromb Haemost. 2020;18(6):1324\u20139. https:\/\/doi.org\/10.1111\/jth.14859","DOI":"10.1111\/jth.14859"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        Zhang L, Long Y, Xiao H, Yang J, Toulon P, Zhang Z. Use of D-dimer in oral anticoagulation therapy. Int J Lab Hematol. 2018;40(5):503\u20137. https:\/\/doi.org\/10.1111\/ijlh.12864","DOI":"10.1111\/ijlh.12864"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"23.        Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol. 2007;44(2):62\u20139. https:\/\/doi.org\/10.1053\/j.seminhematol.2007.02.004","DOI":"10.1053\/j.seminhematol.2007.02.004"},{"key":"ref23","unstructured":"24.        Bauer KA, Lip GY. Overview of the causes of venous thrombosis - UpToDate [Internet]. UpToDate. 2024 [cited 2024 Nov 24]. Available from: https:\/\/www.uptodate.com\/contents\/overview-of-the-causes-of-venous-thrombosis?search=virchow&source=search_result&selectedTitle=2~26&usage_type=default&display_rank=2"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.        Cruz DA, Sousa I de L, Santana PVD, Oliveira LK de A, Sousa FW dos S, Ara\u00fajo \u00c1MX de, et al. Impacts of invasive mechanical ventilation on patients from COVID-19: integrative review. Res Soc Dev. 2021;10(11):e380101119656. https:\/\/doi.org\/10.33448\/rsd-v10i11.19656","DOI":"10.33448\/rsd-v10i11.19656"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26.        Hua J, Qian C, Luo Z, Li Q, Wang F. Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan. Crit Care. 2020;24(1):348. https:\/\/doi.org\/10.1186\/s13054-020-03044-9","DOI":"10.1186\/s13054-020-03044-9"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27.        King CS, Sahjwani D, Brown AW, Feroz S, Cameron P, Osborn E, et al. Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS One. 2020;15(11):e0242651. https:\/\/doi.org\/ 10.1371\/journal.pone.0242651","DOI":"10.1371\/journal.pone.0242651"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.        Tamara A, Tahapary DL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes Metab Syndr. 2020;14(4):655\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2020.05.020","DOI":"10.1016\/j.dsx.2020.05.020"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.        Crous-Bou M, Harrington LB, Kabrhel C. Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost. 2016;42(8):808\u2013820. https:\/\/doi.org\/10.1055\/s-0036-1592333","DOI":"10.1055\/s-0036-1592333"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.        Aghili SMM, Ebrahimpur M, Arjmand B, Shadman Z, Pejman Sani M, Qorbani M, et al. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis. Int J Obes (Lond). 2021;45(5):998\u20131016. https:\/\/doi.org\/10.1038\/s41366-021-00776-8","DOI":"10.1038\/s41366-021-00776-8"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.        Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182\u20139. https:\/\/doi.org\/10.1001\/archinte.162.10.1182","DOI":"10.1001\/archinte.162.10.1182"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32.        Sacak ME, Karacabey S, Sanri E, Omercikoglu S, \u00dcnal E, Onur \u00d6E, et al. Variables Affecting Mortality Among COVID-19 Patients With Lung Involvement Admitted to the Emergency Department. Cureus. 2021;13(1):e12559. https:\/\/doi.org\/10.7759\/cureus.12559","DOI":"10.7759\/cureus.12559"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.        Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, et al. Predictors of COVID-19 severity: A literature review. Rev Med Virol. 2021;31(1):1\u201310. https:\/\/doi.org\/10.1002\/rmv.2146","DOI":"10.1002\/rmv.2146"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.        Francone M, Iafrate F, Masci GM, Coco S, Cilia F, Manganaro L, et al. Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis. Eur Radiol. 2020;30(12):6808\u201317. https:\/\/doi.org\/10.1007\/s00330-020-07033-y","DOI":"10.1007\/s00330-020-07033-y"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.        Harrison SL, Buckley BJR, Rivera-Caravaca JM, Zhang J, Lip GYH. Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews. Eur Hear J Qual Care Clin Outcomes. 2021;7(4):330\u20139. https:\/\/doi.org\/10.1093\/ehjqcco\/qcab029","DOI":"10.1093\/ehjqcco\/qcab029"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.        N\u00e4gele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58\u201362. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.10.014","DOI":"10.1016\/j.atherosclerosis.2020.10.014"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.        Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, et al. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022;399(10319):50\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(21)02392-8","DOI":"10.1016\/s0140-6736(21)02392-8"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.        Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018;2(22):3257\u201391. https:\/\/doi.org\/10.1182\/bloodadvances.2018024893","DOI":"10.1182\/bloodadvances.2018024893"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39.        Ageno W, Donadini M. Breadth of complications of long-term oral anticoagulant care. Hematology Am Soc Hematol Educ Program. 2018;2018(1):432\u20138. https:\/\/doi.org\/10.1182\/asheducation-2018.1.432","DOI":"10.1182\/asheducation-2018.1.432"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"40.        Spyropoulos AC, Levy JH, Ageno W, Connors JM, Hunt BJ, Iba T, et al. Scien-tific and Standardization Committee communication: Clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859\u201365. https:\/\/doi.org\/10.1111\/jth.14929","DOI":"10.1111\/jth.14929"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:04:55Z","timestamp":1740171895000},"score":1,"resource":{"primary":{"URL":"https:\/\/jornaldepneumologia.com.br\/details\/4074\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":40,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20240042","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]}}}